Menu

Top Stories

Giants in chest medicine: Gerard M. Turino, MD

Giants in chest medicine: Gerard M. Turino, MD
Thursday, December 13, 2018
“My initial encounter with Gerry Turino took place in 1976, during my first year as a pathology intern at Columbia-Presbyterian Hospital. I was referred to him by a colleague, after mentioning my interest in connective tissue research. When I entered Gerry’s office and began talking about my desire to join his research group, I immediately sensed his warmth and willingness to...
Divider

Medicare Open Enrollment for 2019 coverage

Thursday, December 6, 2018
Medicare health and drug plan holders can make changes annually on costs, coverage, and which providers and pharmacies are in their networks. From October 15th, 2018, through December 7th, 2018, people with Medicare can change their health plan...
Divider

Zemaira update

Tuesday, December 4, 2018
The Alpha-1 Foundation was informed by CSL Behring that Zemaira, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin Deficiency (Alpha-1), returned to normal distribution on Monday, December 3rd, 2018. This is...
Divider

Alpha-1 Foundation announces new Director of Communications

Monday, December 3, 2018
The Alpha-1 Foundation announces the appointment of Jeanne Kushner as the new Director of Communications. Kushner leaves her position as Senior Director of Development at the Foundation where she has overseen the Development Department and...
Divider

Alpha-1 friend Lynn Lothian passes away

Monday, November 26, 2018
It is with a heavy heart that the Alpha-1 Foundation shares the passing of Lynn Martine Lothian at the age of 61. Lynn began her leadership in the Alpha-1 community in 2007, when she started leading the Maryland Alpha-1 support group. When she...
Divider

Looking beyond mortality in transplantation outcomes

Tuesday, November 20, 2018
To the Centers for Medicare and Medicaid Services (CMS), whose benchmarks are the basis for whether a program is certified as a transplant center, success means being alive one year after transplantation, regardless of the quality of life of the...
Divider

Gordon L. Snider Critical Issues Workshop to focus on the COPD National Action Plan and Alpha-1

Wednesday, November 14, 2018
The 17th Gordon L. Snider Critical Issues Workshop, titled “The Alpha-1 Foundation Approach to the COPD National Action Plan” is being held on November 15th, 2018, in New York, NY, and includes expert representation from academia,...
Divider

Escape to the Cape: Team Alpha-1 made it happen, again

Thursday, November 8, 2018
Written by Judith Vargas-Vila Every September, the scenic coast of Cape Cod, Massachusetts, is the perfect stage for the annual Escape to the Cape fundraising bike trek, a 165-mile bicycle ride from Plymouth to Provincetown. An unforgettable...
Divider

Papers on Alpha-1 research published in the COPD Foundation Journal

Wednesday, November 7, 2018
The latest issue of the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (Volume 5, Issue 4 – 2018) features papers from presenters at the “3rd Biennial International Research Conference on Alpha-1...
Divider

Mereo BioPharma and TAP work together in clinical study

Tuesday, November 6, 2018
Mereo BioPharma Group plc announced a collaboration with (and investment from) the venture philanthropy arm of the Alpha-1 Foundation, The Alpha-1 Project, Inc. (TAP) in Mereo’s MPH-966 development program. MPH-966 is an oral neutrophil...
Divider

Grifols affirms commitment to patients during Alpha-1 Awareness Month

Friday, November 2, 2018
November is Alpha-1 Awareness Month, and Grifols is proud to share its efforts to further increase Alpha-1 diagnosis rates and expand treatment options. Alpha-1 awareness matters. Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic condition...
Divider

Significant reduction in Alzheimer progression demonstrated

Thursday, November 1, 2018
Grifols (Spain) announced that the combination of Plasmapheresis, a well-known and safe procedure used in plasma exchange, with Albutein® 20% (Albumin - a safe, well tolerated plasma protein with multiple properties) has demonstrated a...
Divider

Alpha John Taylor passes away

Thursday, November 1, 2018
It is with a heavy heart that the Alpha-1 Foundation announces the passing of John Taylor, on September 29th, 2018. He was 60 years old. John led an incredible childhood in the town of Delran, New Jersey. He spread his wings and moved to...
Divider
12345678910Last

Article Search

Enter keywords in text box and click Search button for results.

Archive